| 1H NMR Monitoring of the Canine Metabolic Profile after Oral Administration of Xenobiotics Using Multivariate Statistics MA Constantinou, M Vertzoni, C Reppas, A Tsantili-Kakoulidou, E Mikros Molecular Pharmaceutics 4 (2), 258-268, 2007 | 4 | 2007 |
| 5 Estimation of intraluminal drug solubility C Reppas, M Vertzoni Solubility in Pharmaceutical Chemistry, 133, 2020 | | 2020 |
| A LC-MS-MS method for determination of low doxazosin concentrations in plasma after oral administration to dogs M Erceg, M Cindric, LP Frketic, M Vertzoni, B Cetina-Cižmek, C Reppas Journal of chromatographic science 48 (2), 114-119, 2010 | 21 | 2010 |
| Albendazole vs. albendazole sulphate in the fasted upper gastrointestinal lumen based on ex vivo and in vitro data A Kourentas, M Vertzoni, I Khadra, G Halbert, H Clark, J Butler, C Reppas American Association of Pharmaceutical Scientists, 2014 | | 2014 |
| An in vitro biorelevant gastrointestinal transfer (BioGIT) system for forecasting concentrations in the fasted upper small intestine: design, implementation, and evaluation A Kourentas, M Vertzoni, N Stavrinoudakis, A Symillidis, J Brouwers, ... European Journal of Pharmaceutical Sciences 82, 106-114, 2016 | 64 | 2016 |
| An In Vitro Methodology for Forecasting Luminal Concentrations and Precipitation of Highly Permeable Lipophilic Weak Bases in the Fasted Upper Small Intestine D Psachoulias, M Vertzoni, J Butler, D Busby, M Symillides, J Dressman, ... Pharmaceutical research 29, 3486-3498, 2012 | 99 | 2012 |
| AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION OF PHARMACEUTICAL SCIENTISTS DT Burns, F Erni | | |
| Analyzing Parametric Influences Driving Age-Associated Changes in Absorption using a PBPK-GSA Approach D Robins, A Lehmann, K Krollik, M Vertzoni European Journal of Pharmaceutical Sciences, 106881, 2024 | | 2024 |
| Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form E Jantratid, V De Maio, E Ronda, V Mattavelli, M Vertzoni, JB Dressman European Journal of Pharmaceutical Sciences 37 (3-4), 434-441, 2009 | 182 | 2009 |
| Biopharmaceutical considerations in paediatrics with a view to the evaluation of orally administered drug products–a PEARRL review M Guimarães, M Statelova, R Holm, C Reppas, M Symilllides, M Vertzoni, ... Journal of Pharmacy and Pharmacology 71 (4), 603-642, 2019 | 37 | 2019 |
| Biorelevant dissolution methods and their applications in in vitro-in vivo correlations for oral formulations N Fotaki, M Vertzoni The Open Drug Delivery Journal 4 (1), 2010 | 143 | 2010 |
| Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles D Juenemann, E Jantratid, C Wagner, C Reppas, M Vertzoni, ... European journal of pharmaceutics and biopharmaceutics 77 (2), 257-264, 2011 | 127 | 2011 |
| Biorelevant in-vitro performance testing of orally administered dosage forms C Reppas, M Vertzoni Journal of Pharmacy and Pharmacology 64 (7), 919-930, 2012 | 61 | 2012 |
| Biorelevant media for transport experiments in the Caco-2 model to evaluate drug absorption in the fasted and the fed state and their usefulness C Markopoulos, F Thoenen, D Preisig, M Symillides, M Vertzoni, N Parrott, ... European Journal of Pharmaceutics and Biopharmaceutics 86 (3), 438-448, 2014 | 56 | 2014 |
| Biorelevant media to simulate fluids in the ascending colon of humans and their usefulness in predicting intracolonic drug solubility M Vertzoni, A Diakidou, M Chatzilias, E Söderlind, B Abrahamsson, ... Pharmaceutical research 27, 2187-2196, 2010 | 136 | 2010 |
| Challenges in permeability assessment for oral drug product development M Koziolek, P Augustijns, C Berger, R Cristofoletti, D Dahlgren, J Keemink, ... Pharmaceutics 15 (10), 2397, 2023 | 4 | 2023 |
| Characteristics of contents in the upper gastrointestinal lumen after a standard high-calorie high-fat meal and implications for the in vitro drug product performance testing … C Pentafragka, M Vertzoni, J Dressman, M Symillides, K Goumas, ... European Journal of Pharmaceutical Sciences 155, 105535, 2020 | 22 | 2020 |
| Characteristics of contents of lower intestine in the 65–74 years of age range could impact the performance of safe and efficacious modified release products M Vertzoni, S Sulaiman, K Goumas, E Kersten, J Anlahr, U Muenster, ... Journal of Pharmaceutical Sciences 110 (1), 251-258, 2021 | 14 | 2021 |
| Characteristics of the human upper gastrointestinal contents in the fasted state under hypo-and A-chlorhydric gastric conditions under conditions of typical drug–drug … C Litou, M Vertzoni, C Goumas, V Vasdekis, W Xu, F Kesisoglou, ... Pharmaceutical research 33, 1399-1412, 2016 | 86 | 2016 |
| Characterization of contents of distal ileum and cecum to which drugs/drug products are exposed during bioavailability/bioequivalence studies in healthy adults C Reppas, E Karatza, C Goumas, C Markopoulos, M Vertzoni Pharmaceutical research 32, 3338-3349, 2015 | 76 | 2015 |
